Neuropediatrics 2021; 52(05): 394-397
DOI: 10.1055/s-0040-1715627
Short Communication

A Presentation of Pediatric Sjögren's Syndrome with Abducens Nerve Palsy

1   Department of Pediatrics, Department of Radiology, Emory University School of Medicine, Atlanta, Georgia, United States
2   Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
,
Judith A. Gadde
3   Department of Radiology, Emory University School of Medicine, Atlanta, Georgia, United States
4   Department of Radiology, Ann & Robert Lurie Children’s Hospital of Chicago, Northwestern University, Chicago, Illinois, Unites States
,
Elaine Flanagan
1   Department of Pediatrics, Department of Radiology, Emory University School of Medicine, Atlanta, Georgia, United States
2   Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
,
Grace Gombolay
1   Department of Pediatrics, Department of Radiology, Emory University School of Medicine, Atlanta, Georgia, United States
2   Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
› Author Affiliations

Abstract

Sjögren's syndrome is a systemic autoimmune disease that classically presents with xerophthalmia and xerostomia. However, neurological manifestations occur in 10 to 60% of patients with Sjögren's syndrome and can often precede classic sicca symptoms in Sjögren's syndrome in some cases up to several years. Rarely, cranial neuropathy can be the initial presentation. Here, we present the first case of a 15-year-old girl with left abducens palsy in the setting of a new diagnosis of Sjögren's syndrome. Comprehensive evaluation revealed elevated Sjögren's syndrome–related antigen A-60 antibody. Cerebrospinal fluid analysis was unremarkable. Radiological studies demonstrated evidence of chronic parotitis. Acute treatment included high-dose methylprednisolone and rituximab, and symptoms resolved by follow-up at 2 weeks. The most common neurological disorder of Sjögren's syndrome is pure sensory neuropathy. In pediatric Sjögren's syndrome, neurological complications are rare but include aseptic meningoencephalitis, acute disseminated encephalomyelitis, transverse myelitis, optic neuritis, and cranial neuropathies. In the circumstance of a cranial neuropathy, the trigeminal nerve is most commonly involved but oculomotor nerves can occasionally be affected. Abducens palsies have been described in four patients with Sjögren's syndrome, typically women and all middle aged or older, with our patient being the first pediatric case. Thus, it is important to consider screening for Sjögren's syndrome in the evaluation of pediatric patients with new onset of isolated cranial neuropathy even in the absence of classic sicca symptoms.



Publication History

Received: 18 March 2020

Accepted: 02 July 2020

Article published online:
14 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Sumida T, Azuma N, Moriyama M. et al. Clinical practice guideline for Sjögren's syndrome 2017. Mod Rheumatol 2018; 28 (03) 383-408
  • 2 Teixeira F, Moreira I, Silva AM, Vasconcelos C, Farinha F, Santos E. Neurological involvement in primary Sjögren syndrome. Acta Reumatol Port 2013; 38 (01) 29-36
  • 3 Matsui Y, Takenouchi T, Narabayashi A, Ohara K, Nakahara T, Takahashi T. Childhood Sjögren syndrome presenting as acute brainstem encephalitis. Brain Dev 2016; 38 (01) 158-162
  • 4 Shiboski CH, Shiboski SC, Seror R. et al; International Sjögren's Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017; 69 (01) 35-45
  • 5 Yokogawa N, Lieberman SM, Sherry DD, Vivino FB. Features of childhood Sjögren's syndrome in comparison to adult Sjögren's syndrome: considerations in establishing child-specific diagnostic criteria. Clin Exp Rheumatol 2016; 34 (02) 343-351
  • 6 Verstappen GM, van Nimwegen JF, Vissink A, Kroese FGM, Bootsma H. The value of rituximab treatment in primary Sjögren's syndrome. Clin Immunol 2017; 182: 62-71
  • 7 Berman JL, Kashii S, Trachtman MS, Burde RM. Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child. Ophthalmology 1990; 97 (12) 1606-1609
  • 8 Gottfried JA, Finkel TH, Hunter JV, Carpentieri DF, Finkel RS. Central nervous system Sjögren's syndrome in a child: case report and review of the literature. J Child Neurol 2001; 16 (09) 683-685
  • 9 Ohtsuka T, Saito Y, Hasegawa M. et al. Central nervous system disease in a child with primary Sjögren syndrome. J Pediatr 1995; 127 (06) 961-963
  • 10 Rojas-Rodriguez J, Garcia-Carrasco M, Ramirez ES. et al. Optic neuropathy in a child with primary Sjögren's syndrome. Rev Rhum Engl Ed 1998; 65 (05) 355-357
  • 11 DeGuzman M, Fishman MA, Lewis RA, McCluggage C, Warren RW, Finegold MJ. Chronic neurologic disease with visual, gait, and bladder problems in a male teenager. J Pediatr 1998; 132 (04) 742-747
  • 12 Mori K, Iijima M, Koike H. et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005; 128 (Pt 11): 2518-2534
  • 13 Sakai K, Hamaguchi T, Yamada M. Multiple cranial nerve enhancement on MRI in primary Sjögren's syndrome. Intern Med 2010; 49 (09) 857-859
  • 14 Ibrahem HM. B cell dysregulation in primary Sjögren's syndrome: A review. Jpn Dent Sci Rev 2019; 55 (01) 139-144
  • 15 Margaretten M. Neurologic Manifestations of Primary Sjögren Syndrome. Rheum Dis Clin North Am 2017; 43 (04) 519-529